Related Experiment Video
Updated: May 12, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
Rebecca J Fairclough1, Matthew J Wood, Kay E Davies
1Department of Physiology, Anatomy and Genetics, University of Oxford, Parks Road, Oxford OX1 3PT, UK.
Abstract:
Duchenne muscular dystrophy (DMD) is a devastating progressive disease for which there is currently no effective treatment except palliative therapy. There are several promising genetic approaches, including viral delivery of the missing dystrophin gene, read-through of translation stop codons, exon skipping to restore the reading frame and increased expression of the compensatory utrophin gene. The lessons learned from these approaches will be applicable to many other disorders.
Related Concept Videos
Gene Therapy
Gene Therapy
Satellite Stem Cells and Muscular Dystrophy
Pharmacogenomics: Identification of New Drug Targets
What is Genetic Engineering?
Animal Mitochondrial Genetics

